Cns Drugs, 1172-7047

Journal

View graph of relations

Related Publications
  1. Targeting Neuroinflammation to Treat Alzheimer's Disease

    Ardura-Fabregat, A., Boddeke, E. W. G. M., Boza-Serrano, A., Brioschi, S., Castro-Gomez, S., Ceyzeriat, K., Dansokho, C., Dierkes, T., Gelders, G., Heneka, M. T., Hoeijmakers, L., Hoffmann, A., Iaccarino, L., Jahnert, S., Kuhbandner, K., Landreth, G., Lonnemann, N., Loeschmann, P. A., McManus, R. M., Paulus, A., Reemst, K., Sanchez-Caro, J. M., Tiberi, A., Van der Perren, A., Vautheny, A., Venegas, C., Webers, A., Weydt, P., Wijasa, T. S., Xiang, X. & Yang, Y., Dec-2017, In : Cns Drugs. 31, 12, p. 1057-1082 26 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  2. Erratum to: Health-Related Quality of Life in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs

    Jongen, P. J., Jul-2017, In : Cns Drugs. 31, 7, p. 603-603 1 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  3. Health-Related Quality of Life in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs

    Jongen, P. J., Jul-2017, In : Cns Drugs. 31, 7, p. 585-602 18 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  4. Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era

    Alvarez-Jimenez, M., O'Donoghue, B., Thompson, A., Gleeson, J. F., Bendall, S., Gonzalez-Blanch, C., Killackey, E., Wunderink, L. & McGorry, P. D., May-2016, In : Cns Drugs. 30, 5, p. 357-368 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (12) »

ID: 1245993